Search research articles
Contact Us
Filters
Showing results (111-120 of 121) with videos related to
Page
of 13
Sort By:
BMJ Open
|
September 29, 2022
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for type 2 diabetes remission (ORDER): protocol of a multicentre, randomised controlled, open-label, superiority trial
Mengyi Li, Yang Liu, Wei-Jei Lee, et al.
Molecular & Cellular Proteomics : MCP
|
August 21, 2015
A High Through-put Platform for Recombinant Antibodies to Folded Proteins
Michael Hornsby, Marcin Paduch, Shane Miersch, et al.
Nature Genetics
|
September 18, 2025
Pan-UK Biobank genome-wide association analyses enhance discovery and resolution of ancestry-enriched effects
Konrad J Karczewski, Rahul Gupta, Masahiro Kanai, et al.
JCO Precision Oncology
|
March 6, 2025
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group
Lakshmi Rajdev, Gentry G King, Christopher H Lieu, et al.
Journal of Medicinal Chemistry
|
October 20, 2018
Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers
Julien P N Papillon, Katsumasa Nakajima, Christopher D Adair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
Jennifer J Knox, Grainne O'Kane, Daniel King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2025
Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
Jennifer J Knox, Grainne O'Kane, Daniel King, et al.
Nature Genetics
|
October 6, 2015
Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families
Nadia Akawi, Jeremy McRae, Morad Ansari, et al.
Cell Genomics
|
February 13, 2023
Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes
Konrad J Karczewski, Matthew Solomonson, Katherine R Chao, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 3, 2026
Integrating 730,947 exome sequences with clinical literature improves gene discovery
Jeremy Guez, Julia K Goodrich, Mikhail A Moldovan, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 121) with videos related to
Sort By:
Page
of 13
BMJ Open
|
September 29, 2022
Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for type 2 diabetes remission (ORDER): protocol of a multicentre, randomised controlled, open-label, superiority trial
Mengyi Li, Yang Liu, Wei-Jei Lee, et al.
Molecular & Cellular Proteomics : MCP
|
August 21, 2015
A High Through-put Platform for Recombinant Antibodies to Folded Proteins
Michael Hornsby, Marcin Paduch, Shane Miersch, et al.
Nature Genetics
|
September 18, 2025
Pan-UK Biobank genome-wide association analyses enhance discovery and resolution of ancestry-enriched effects
Konrad J Karczewski, Rahul Gupta, Masahiro Kanai, et al.
JCO Precision Oncology
|
March 6, 2025
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group
Lakshmi Rajdev, Gentry G King, Christopher H Lieu, et al.
Journal of Medicinal Chemistry
|
October 20, 2018
Discovery of Orally Active Inhibitors of Brahma Homolog (BRM)/SMARCA2 ATPase Activity for the Treatment of Brahma Related Gene 1 (BRG1)/SMARCA4-Mutant Cancers
Julien P N Papillon, Katsumasa Nakajima, Christopher D Adair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 10, 2025
PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
Jennifer J Knox, Grainne O'Kane, Daniel King, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2025
Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer
Jennifer J Knox, Grainne O'Kane, Daniel King, et al.
Nature Genetics
|
October 6, 2015
Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families
Nadia Akawi, Jeremy McRae, Morad Ansari, et al.
Cell Genomics
|
February 13, 2023
Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes
Konrad J Karczewski, Matthew Solomonson, Katherine R Chao, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 3, 2026
Integrating 730,947 exome sequences with clinical literature improves gene discovery
Jeremy Guez, Julia K Goodrich, Mikhail A Moldovan, et al.
Page
of 13